Tamoxifen attenuates the effects of exogenous glucocorticoid on bone formation and growth in piglets

Endocrinology

Volumn 139, Issue 8, 1998, Pages 3399-3403

  Fritz, P C ^b   Ward, W E ^b   Atkinson, S A ^b   Tenenbaum, H C ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; TAMOXIFEN;

ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE GROWTH; BONE METABOLISM; DRUG EFFECT; GROWTH INHIBITION; HORMONAL REGULATION; INTRAGASTRIC DRUG ADMINISTRATION; MALE; NONHUMAN; OSSIFICATION; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; SWINE;

EID: 0031730725     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.8.6158     Document Type: Article

References (30)

1. Fentiman IS, Saad Z, Caleffi M, Chaudary MA, Fogelman I 1992 Tamoxifen protects against steroid-induced bone loss. Eur J Cancer 28:684-685
2. Wolthers OD, Pedersen S 1990 Short term linear growth in asthmatic children during treatment with prednisolone, Br Med J 301:145-148
3. Allen DB, Goldberg BD 1992 Stimulaton of collagen synthesis and linear growth by growth hormone in glucocorticoid-treated children. Pediatrics 89:416-421
4. Weiler HA, Paes B, Shah JK, Atkinson SA 1997 Longitudinal assessment of growth and bone mineral accretion in prematurely born infants treated for chronic lung disease with dexamethasone. Early Hum Dev 47:271-286
5. Halton JM, Atkinson SA, Fraher L, Webber C, Gill GJ, Dawson S, Barr RD 1996 Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Miner Res 11:1774-1783
6. Canalis E 1996 Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 81:3441-3447
7. Maniatopoulos C, Sodek J, Melcher AH 1988 Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res 254:317-330
8. Tenenbaum HC, Heersche JNM 1984 Dexamethasone stimulates osteogenesis in chick periosteum in vitro. Endocrinology 117:2211-2217
9. Kamalia N, McCulloch CAG, Tenenbaum HC, Limeback H 1992 Dexamethasone recruitment of self-renewing osteoprogenitor cells in chick bone marrow stromal cell cultures. Blood 79:320-326
10. Sukhu B, Rotenberg B, Binkert C, Kohno H, Zohar R, McCulloch CAG, Tenenbaum HC 1997 Tamoxifen attenuates glucocorticoid actions on bone formation in vitro. Endocrinology 138:3269-3275
11. Tenenbaum HC, Kamalia N, Sukhu B, Limeback H, McCulloch CAG 1995 Probing glucocorticoid-dependent osteogenesis in rat and chick cells in vitro by specific blockade of osteoblastic differentiation with progesterone and RU38486. Anat Rec 242:200-210
12. Barengolts EI, Lathon PV, Lindh FG 1995 Progesterone antagonist RU 486 has bone-sparing effects in ovariectomized rats. Bone 17:21-25
13. Weiler HA, Wang Z, Atkinson SA 1995 Dexamethasone treatment impairs calcium regulation and bone mineralization in infant piglets. Am J Clin Nutr 61:805-811
14. Brunton JA, Weiler HA, Atkinson SA 1997 Improvement in the accuracy of dual energy x-ray absorptiometry for whole body and regional analysis of body composition: Validation using piglets and methodological considerations in infants. Pediatr Res 41:1-7
15. Grainger DJ, Metcalfe JC 1996 Tamoxifen: teaching an old drug new tricks? Nat Med 2:381-385
16. Kalu DN, Salerno E, Liu CC, Echon R, Ray M, Carza-Zapata M, Hollis BW 1991 A comparative study of the actions of tamoxifen, estrogen and progesterone in the ovariectomized rat. Bone Miner 15:109-124
17. Wright CDP, Compston JE 1995 Tamoxifen: oestrogen or anti-oestrogen in bone? Q J Med 88:307-310
18. Ward RL, Morgan G, Dalley D, Kelly PJ 1993 Tamoxifen reduces bone turnover and prevents lumbar spine and proximal femoral bone loss in early postmenopausal women. Bone Miner 22:87-94
19. Love RR, Mazess RB, Barden HS, Epstein S, Newcomb PA, Jordan VC, Carbone PP, DeMets DL 1992 Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 326:852-856
20. Li X, Takahashi M, Kushida K, Koyama S, Hoshino H, Kawana K, Horiuchi K, Inoue T 1996 The effect of tamoxifen on bone metabolism and skeletal growth is different in ovariectomized and intact rats. Calcif Tissue Int 59:271-276
21. Williams DC, Paul DC, Black LJ 1991 Effects of estrogen and tamoxifen on serum osteocalcin levels in ovariectomized rats. Bone Miner 14:205-220
22. Ke HZ, Chen HK, Simmons HA, Crawford DT, Pirie CM, Chidsey-Frink KL, Ma YF, Jee WSS, Thompson DD 1997 Comparative effects of droloxifiene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model. Bone 20:31-39
23. Fukazawa Y, Nobata S, Katoh M, Tanaka M, Kobayashi S, Ohta Y, Hayashi Y, Iguchi T 1996 Effect of neonatal exposure to diethylstilbestrol and tamoxifen on pelvis and femur in male mice. Anat Rec 244:416-422
24. Evans GL, Turner RT 1995 Tissue-selective actions of estrogen analogs. Bone 17:181S-190S
25. Fenitman IS, Fogelman I 1993 Breast cancer and osteoporosis-a bridge at last. Eur J Cancer 29A:485-486
26. Engle MJ, Kemnitz JW, Rao TJ, Perleman RH, Farrell PM 1996 Effects of maternal dexamethasone therapy on fetal lung development in the rhesus monkey. Am J Perinatol 13:399-407
27. Jayyosi Z, Muc M, Erick J, Thomas PE, Michael K 1996 Catalytic and immunochemical characterization of cytochrome P450 isozyme induction in dog liver. Fund Appl Toxicol 31:95-102
28. Odedra BR, Bates PC, Millward DJ 1983 Time course of the effect of catabolic doses of corticosterone on protein turnover in rat skeletal muscle and liver. Biochem J 214:617-627
29. Bensoussan C, Delaforge M, Mansuy D 1995 Particular ability of cytochromes P450 3A to form inhibitory P450-iron-metabolite complexes upon metabolic oxidation of aminodrugs. Biochem Pharamacol 49:591-602
30. Jordan CV 1984 Biochemical pharmacology of antiestrogen action. Pharmacol Rev 36:245-276